Lorena Boulanger Pharma SRL
Lorena Boulanger Pharma reported total assets of 32,165 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of Lorena Boulanger Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +352 % Total assets +91 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lorena Boulanger Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Lorena Boulanger Pharma's financial analysis
- Solvency80.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lorena Boulanger Pharma
Lorena Boulanger Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0758.731.822
- VAT number
- BE0758731822
- Peppol
- Registered · 0208:0758731822 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Nov 2020
- Registered office
- 7160 Chapelle-lez-Herlaimont
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lorena Boulanger Pharma (SRL) has been based in Chapelle-lez-Herlaimont since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,065 € and equity of 25,925 €; its revenue is not published. Its solvency stands at 80.6%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lorena Boulanger Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
- AB Society Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 31,595 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
- Pharmavanty Retail sale of pharmaceutical products Ninove · balance sheet 34,846 €
- Espace Medical Jumet Retail sale of pharmaceutical products Charleroi · balance sheet 29,613 €
- BLAIRVACQ Jean François Retail sale of pharmaceutical products Waremme · balance sheet 29,415 €
Frequently asked questions about Lorena Boulanger Pharma
What is the revenue of Lorena Boulanger Pharma?
Lorena Boulanger Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lorena Boulanger Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0758731822 for Lorena Boulanger Pharma, if the company is VAT-registered. Its company number (CBE) is 0758.731.822.
Where is the registered office of Lorena Boulanger Pharma?
According to the CBE register, the registered office of Lorena Boulanger Pharma is in 7160 Chapelle-lez-Herlaimont.
What is the equity of Lorena Boulanger Pharma?
At the close of the 2025 financial year, the equity of Lorena Boulanger Pharma amounts to 25,925 €, a solvency of 80.6% of total assets.
Who manages Lorena Boulanger Pharma?
The register lists 1 active mandates at Lorena Boulanger Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lorena Boulanger Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →